An internal stoush at the drug-buying agency Pharmac has blocked funding for a life-extending drug for bowel cancer patients, that's available in 52 other countries.
Meanwhile, patients are going into debt to pay tens of thousands of dollars for the drug Cetuximab, which can extend their lives by months or even years.
Ruth Hill reports.
